Abbonarsi

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation - 21/08/11

Doi : 10.1016/j.ahj.2004.09.053 
Charles R. Kerr, MD a, , Karin H. Humphries, DSc a, Mario Talajic, MD b, George J. Klein, MD c, Stuart J. Connolly, MD d, Martin Green, MD e, John Boone, MD a, Robert Sheldon, MD, PhD f, Paul Dorian, MD g, David Newman, MD g
a Department of Medicine, University of British Columbia, Vancouver, BC, Canada 
b Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada 
c Department of Medicine, University of Western Ontario, London, Ontario, Canada 
d Department of Medicine, McMaster University, Hamilton, Ontario, Canada 
e Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada 
f Department of Medicine, University of Calgary, Calgary, Alberta, Canada 
g Department of Medicine, University of Toronto, Toronto, Ontario, Canada 

 Reprint requests: Charles R. Kerr, MD, Division of Cardiology, St Paul's Hospital, Room 344, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6.

Riassunto

Background

After its initial diagnosis, atrial fibrillation (AF) may progress from paroxysmal to chronic AF (CAF). The rate of progression and risk factors for progression are not clearly defined.

Methods

The Canadian Registry of Atrial Fibrillation (CARAF) enrolled patients from 6 Canadian cities at the time of their first electrocardiographic diagnosis of AF. Comprehensive clinical and echocardiographic data were collected and patients were followed annually, carefully documenting clinical outcomes, recurrence of paroxysmal AF, and progression to CAF. Baseline clinical, electrocardiographic, and echocardiographic variables were evaluated by univariate Cox proportionate hazards analysis. A stepwise approach was used to model the association between echocardiographic and clinical variables with progression to CAF.

Results

A total of 757 patients with a baseline diagnosis of paroxysmal AF were evaluated. Median follow-up was 8.0 years (range 2 days to 11.1 years). The probability of progression to CAF by 1 year was 8.6% and thereafter there was a slow but steady progression to 24.7% by 5 years. By 5 years, the probability of documented recurrence of any AF (chronic or paroxysmal) was 63.2%. Increasing age, significant aortic stenosis or mitral regurgitation, left atrial enlargement, and diagnosis of cardiomyopathy were independently associated with progression to CAF. A more rapid heart rate during AF was associated with decreased risk of progression.

Conclusions

After the initial diagnosis of paroxysmal AF, there is a slow but steady progression to CAF. Baseline echocardiographic variables, age, cardiomyopathy, and heart rate were independently associated with progression to CAF.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 The CARAF Study is currently supported by an unrestricted research grant from Procter and Gamble Pharmaceuticals (1998-2002) and was previously supported by Knoll Pharma Canada (1990-1996) and Dupont Pharma Canada (1997).


© 2005  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 149 - N° 3

P. 489-496 - Marzo 2005 Ritorno al numero
Articolo precedente Articolo precedente
  • Reducing the costs of phase III cardiovascular clinical trials
  • Eric L. Eisenstein, Philip W. Lemons, Barbara E. Tardiff, Kevin A. Schulman, M. King Jolly, Robert M. Califf
| Articolo seguente Articolo seguente
  • Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes
  • Yan Zhang, Anna K.Y. Chan, Cheuk-Man Yu, Wynnie W.M. Lam, Gabriel W.K. Yip, Wing-Hong Fung, Nina M.C. So, Mei Wang, John E. Sanderson

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.